Vice President, Pharmaceutical Development

Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn . How we work: PIONEER : We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines. COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine. BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard. How you’ll make an impact: Define and lead the company’s pharmaceutical development strategy across the portfolio, ensuring alignment with corporate priorities and development timelines Provide strategic leadership for preformulation, biopharmaceutics, and formulation development activities supporting discovery, preclinical, and clinical-stage programs Champion innovation in formulation sciences and enabling technologies to address complex drug delivery and bioavailability challenges Drive development and implementation of phase-appropriate drug product development and manufacturing strategies Lead a high-performing Pharmaceutical Development team, in internal activities and management of an external network of CROs, CDMOs, and strategic partners Establish scalable processes, operational frameworks, and best practices to support portfolio growth Provide strategic oversight of outsourced development and manufacturing activities, ensuring quality, timelines, and technical objectives are achieved Lead CMC-related regulatory strategy for drug product development activities, regulatory submissions and health authority interactions Ensure compliance with applicable GMP and regulatory requirements Represent Pharmaceutical Development in due diligence activities, external collaborations, and interactions with other functions Contribute to risk assessment, resource prioritization, and investment decisions as a member of the Technical Operations leadership team Foster strong cross-functional partnerships across Research, Clinical, Regulatory, Quality, Supply Chain, and Program Management to enable efficient advancement of pipeline programs Skills and experience you’ll bring: Ph.D. in Pharmaceutics, Pharmaceutical Sciences, Chemical Engineering, or related discipline with 18+ years of relevant pharmaceutical industry experience Demonstrated success leading pharmaceutical development strategy from discovery through clinical development, with experience supporting commercialization readiness Strong understanding of preformulation, biopharmaceutics, formulation development, and oral solid dose drug product manufacturing for small molecules Deep expertise in formulation approaches for poorly soluble compounds, including application of enabling technologies to improve bioavailability and product performance Proven track record of advancing programs through IND and clinical development milestones and contributing to successful regulatory submissions Strong knowledge of GMP requirements, regulatory expectations, and evolving industry trends Experience building and managing high-performing teams and external partnerships Excellent communication and leadership skills, with the abili